Related Experiment Video
Updated: Jul 12, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Countermeasures against Pulmonary Threat Agents.
Jacqui Marzec1, Srikanth Nadadur2
1National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina.
Inhaled toxicants, including chemical warfare agents and industrial chemicals, pose significant risks for acute lung injury and long-term respiratory complications. Developing effective countermeasures for mass casualty events is crucial.
Area of Science:
- Environmental Health
- Toxicology
- Pulmonary Medicine
Background:
- Inhaled toxicants, ranging from industrial chemicals to chemical warfare agents (CWAs), are a growing concern due to their potential for severe respiratory complications.
- Historical and recent use of CWAs, alongside the risks posed by industrial/agricultural chemicals, highlight the need for understanding acute inhalation toxicity.
- Current emergency treatments are limited to supportive care, emphasizing the need for advanced therapeutic strategies.
Purpose of the Study:
- To review the current understanding of acute toxicity and pathophysiology of select inhaled chemical threats.
- To discuss potential early-stage therapeutic developments for lung injury caused by inhaled toxicants.
- To identify challenges in developing countermeasures for mass casualty situations involving inhaled chemical exposures.
Main Methods:
- This minireview synthesizes current knowledge on the toxicology and pathophysiology of inhaled toxicants.
- It examines the clinical progression of lung injury from various chemical exposures.
- The review discusses existing and potential therapeutic interventions and countermeasure development.
Main Results:
- Acute exposure to industrial irritants and CWAs can lead to immediate respiratory distress, progressing to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).
- Delayed complications include obstructive lung disease and pulmonary fibrosis, necessitating long-term clinical management.
- Effective treatments for acute inhalation injury remain limited, underscoring the need for novel therapeutic approaches.
Conclusions:
- Inhaled chemical threats present a significant and increasing risk in both civilian and military contexts.
- There is an urgent need to develop effective countermeasures to mitigate acute lung injury and subsequent chronic respiratory conditions.
- Further research into early-stage therapeutics and mass-administration strategies is essential for addressing these threats.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pulmonary Embolism I: Introduction
Other Pulmonary Disorders

